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Lesions Induced in Rodent Pancreas
by Azaserine and Other Pancreatic
Carcinogens
by Daniel S. Longnecker*
Focal proliferative changes in the acinar cells of the pancreas of rats have been induced by several
systemically administered carcinogens including azaserine, N-nitrosobis(2-oxopropyl)amine, N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine, and Nb-(N-methyl-N-nitrosocarbamoyl)-L-ornithine (MNCO). Foci,
nodules, and adenomas induced by these carcinogens are usually made up of atypical-appearing acinar
cells that maintain a high degree of differentiation, but a minority of these lesions exhibit anaplastic
cellular changes that suggest the development of malignant potential. Such anaplasia may occupy the
whole of smaller lesions or may occur as a secondary focal change within larger nodules or adenomas.
Many foci and nodules per pancreas have been induced by single or multiple exposures to these known
genotoxic carcinogens, but relatively few of them develop into carcinomas. Azaserine and MNCO have
induced acinar cell carcinomas in rats. Those induced by azaserine have exhibited a broad spectrum of
histologic variants, including ductlike, cystic, and undifferentiated patterns. Higher doses of MNCO have
induced a second pattern of change in the pancreatic lobules of rats, which includes cystic and tubular
ductlike structures that have been called cystic and tubular ductal complexes.
MNCO has also induced focal acinar cell lesions, cystic and tubular ductal complexes, and adenocarcinomas in the pancreas of Syrian golden hamsters. In this species, ductal complexes are much more numerous
than are proliferative lesions of acinar cells, and the histologic appearance of the carcinomas is ductlike.
Hyperplasia and atypical changes were also seen in the epithelium of the intralobular ducts of hamsters.
The response of rats and hamsters to carcinogens that affect the pancreas in both species differs in a
consistent pattern. Proliferative lesions of acinar cells were characteristic of carcinogen-exposed rats
whereas ductal complexes and ductlike neoplasms predominated in hamsters given MNCO.

Introduction
Several chemicals have been demonstrated experimentally to induce carcinomas in the rodent pancreas
(1). Lesions induced by azaserine, N-nitrosobis(2oxopropyl)amine (BOP), N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine (HPOP), and Nb-(N-methyl-N-nitrosocarbamoyl)-L-ornithine (MNCO) in the rat pancreas
will be listed and compared. MNCO has also induced
carcinomas in the pancreas of hamsters (2), and the
effect of this carcinogen will be compared in the two
species. All of the carcinogens to be discussed are
mutagens and have been demonstrated to induce DNA
damage in the pancreas by alkaline elution analysis of
DNA. Thus all of these carcinogens are genotoxic
agents and are classed as initiators.

Azaserine-Induced Lesions
The major experience in our laboratory has been with
azaserine which, although it acts without S-9 as a
*Department of Pathology, Dartmouth Medical School, Hanover,
NH 03756.

bacterial mutagen in the Ames system, appears to be
activated in mammalian cells by a pyridoxal-dependent
enzyme system (3). N-7-Carboxymethylguanine was
identified in DNA from cells exposed to azaserine (4), a
finding consistent with the generation of diazoacetate as
the ultimate reactive carcinogenic species derived from
azaserine by an a,,P-elimination reaction.
Foci of phenotypically altered acinar cells have been
identified in the pancreas as early as 1 month after a
single injection of azaserine. These foci are about the
size of small islets. Some of them have a high mitotic
index in routine histologic sections, and an even higher
labeling index in autoradiograms done to detect S-phase
DNA synthesis (5). As expected from this observation,
some of the foci grow at variable rates and form grossly
visible nodules within 4 to 6 months after azaserine
injection. In the vast majority of these lesions the
acinar cells retain a high degree of differentiation.
Phenotypic changes include reduced zymogen content,
increased cytoplasmic basophilia, and altered nuclear
size and configuration.
Some atypical acinar cell nodules (AACN) reach
diameters of 2 to 3 mm; still fewer, the 3 to 7 mm
size range. Lesions in the latter group that retain a high
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degree of differentiation are designated as adenomas.
An expansile growth pattern may be evidenced by the
compression of adjacent tissue. Foci, nodules, and
adenomas form a size continuum of acinar cell lesions.
Only a small fraction of these lesions appear to have the
potential to develop into neoplasms.
In our experience, neoplasms larger than 7 mm in
diameter usually have histologic evidence of anaplastic
cellular changes suggesting malignancy. Smaller lesions
may also show anaplasia-either partial, in the form
of a focal change within a nodule or adenoma, or total,
where the entire lesion seems to consist of anaplastic
cells. When such changes occur in the absence of local
invasion or metastasis, these lesions have been called
localized carcinomas or carcinoma in situ.
Azaserine-induced carcinomas exhibit a spectrum of
histologic patterns (6). Most show evidence of acinar cell
differentiation. Table 1 presents the classification for
332 azaserine-induced carcinomas that have been collected over a period of 8 years. Most of these patterns
have been described previously, although we have recently identified a carcinoma with extensive squamousappearing areas which has prompted us to add an
adenosquamous type to the list. Some portion of each
carcinoma typically retained acinar cell differentiation,
but about 2% of the neoplasms were uniformly undifferentiated. The existence of such diverse histologic
types of carcinoma in the azaserine/rat model is
significant because of the evidence that all of these
neoplasms have originated through the transformation
of acinar cells. No hyperplastic or atypical changes have
been identified within the epithelium of the ductal
system of azaserine-treated rats.
A characteristic of the azaserine model that deserves
emphasis is the fact that a single exposure to azaserine
can induce dozens of AACN per pancreas. AACN have
been defined by usage to include both small foci and
larger nodules of atypical acinar cells, and are apparently the early precursors to azaserine-induced neoplasms. Multiple-dose regimens of azaserine can induce
more than 100 such lesions per pancreas (7).
The incidence of pancreatic cancer has consistently
Table 1. Histologic types of azaserine-induced pancreatic
carcinoma in rats. A series of 332 such carcinomas have been
classified and the distribution of types is shown.
Histologic type
Acinar cell carcinoma, pure
Well-differentiated
Poorly differentiated
Acinar cell carcinoma mixed with
Ductlike carcinoma
Cystic adenocarcinoma
Microadenocarcinoma
Undifferentiated carcinoma
Adenosquamous carcinoma

Undifferentiated carcinoma, pure
Total

n

%

100
143

30
43

59
4
4
15
1

18
1
1
5
<1

332

2
100

6

been higher in male rats than in female rats by a ratio of
approximately 2:1. This difference in sensitivity to
azaserine between the two sexes is also evident in
nodule-induction studies in which we have demonstrated that 1.4 to 4 times as many nodules appear in
male rats as in female rats after equivalent regimens of
azaserine treatment (7). The basis for this sex difference in sensitivity to azaserine is not known. These
studies have been done mainly in Wistar and Lewis
strain rats. We have shown that Fischer 344 rats of
either sex develop fewer acinar cell lesions in response
to azaserine (7).
Diet has been shown to influence the rate of progression of azaserine-induced lesions. Purified diets high
(20%) in unsaturated fats have been shown to enhance
the rate of progression of azaserine-induced lesions in
comparison to diets that contain the standard (5%) level
of corn oil or a high level of saturated fat (18% coconut
oil plus 2% corn oil). In the azaserine model, pancreatic
neoplasms have increased in incidence and number both
when the diet was fed continuously during a prolonged
period of exposure to azaserine (8), and when, in one
experiment, exposure to azaserine was completed before the test diets were fed (9). The number of tumors
per pancreas has been three to four times as great in the
animals fed diets high in unsaturated fats as in their
controls.

Lesions Induced by Derivatives
of Dipropyinitrosamine
The induction of pancreatic carcinomas in hamsters
by BOP and HPOP has been well characterized (10). In
hamsters, the vast majority of carcinomas have been
classed as ductal in histologic type, although we have
also observed a low incidence of carcinomas with
mixtures of malignant ductlike and acinar cells in
BOP-treated hamsters. Several investigators have reported failing to induce pancreatic neoplasms in rats
treated with BOP or related nitrosamines (11). In
biochemical studies of the effect of BOP and HPOP in
Lewis rats, we observed evidence of damage by means
of an alkaline elution analysis of pancreatic DNA from
treated rats (11). The amount of damage induced by
100 mg/kg of BOP or 40 mg/kg of HPOP appeared to be
less than that induced by carcinogenic doses of azaserine, i.e., 10 to 30 mg/kg, but the complete lack of
pancreatic carcinogenesis in BOP-treated rats was
puzzling. Since we had previously shown that young
rats were more sensitive to AACN induction by azaserine than were older or adult rats (12), we treated a
group of 2 to 3 week-old rats with a single injection of
BOP or HPOP All these rats developed multiple AACN
in their pancreases within 4 months after carcinogen
injection (Fig. 1) (11). We have since observed a group
of young rats treated with a single dose of HPOP for a
longer period (unpublished). Some of the AACN grew
to become adenomas and localized carcinomas, as has
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been described in the azaserine model. Ducts have
remained normal in these rats. The early lesions are
similar in histologic appearance to those that we have
observed in azaserine-treated rats. Thus, we believe the
BOP and HPOP can serve as pancreatic carcinogens in
the rat and our observations to date suggest that the
pathway of histogenesis for resulting carcinomas is
similar to that observed in the azaserine rat model. As
many as 100 AACN and adenomas have been observed
in rats given a single dose of 160 mg/kg of HPOR The
fact that a single exposure to a known genotoxic
carcinogen yields multiple altered cellular foci should
again be emphasized.

Lesions Induced by a
Nitrosourea Amino Acid
MNCO is a nitrosourea that appears to be a directacting carcinogen. The pancreatropism of this compound has been attributed to the presence of the intact
a-amino acid group of ornithine. MNCO is a direct
acting mutagen in the Ames assay (13), and has
damaged pancreatic DNA in rats (14). It is an effective
carcinogen in long-term studies although the incidence
of carcinomas was higher in the kidney, skin, and breast
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than in the pancreas in a one-year study (15). This
discussion will focus on the lesions induced in the
pancreas by MNCO in Wistar rats. Low doses of MNCO
induce AACN, whereas in rats given higher doses there
is progressive replacement of the lobular tissue of the
pancreas by cystic lesions that we have referred to as
cystic ductal complexes. Some of the AACN progress to
become acinar cell adenomas, and acinar cell adenocarcinomas.
The cystic lesions in the pancreas consist of multilocular structures with thin fibrous walls lined by a single
layer of flattened or cuboidal epithelium (Fig. 2). Such
lesions appear to replace acinar cells and may appear
around or within islets. The ratio of the diameter of the
lumen to the thickness of the wall is high-in the
range of 10/1 or higher. The mitotic index of the
lining epithelium is low, and most lesions remain
smaller than 3 mm in diameter. We have not seen large
neoplasms of a comparable histologic appearance. For
this reason we believe that the proliferative potential
of these lesions is low or nonexistent.
Acinar tissue is less frequently replaced by lesions of
second
type that we have designated as tubular ductal
a
complexes. These consist of ductlike structures, usually
with a scant fibrous stroma, lined by cuboidal or
columnar epithelium. These elements may be intimately
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FIGURE 1. Nodule of well-differentiated atypical acinar cells from the pancreas of a 4.5-month-old Lewis rat that received a single 100 mg/kg
injection of BOP at 14 days of age. The mitotic index was greater in the nodule than in the adjacent pancreas. Hematoxylin and eosin, x 50.
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FIGURE 2. Cystic ductal complex from the pancreas of a rat killed 3 months after injection of MNCO. The cystic spaces are lined by flattened
epithelium. H & E, x 325.

interspersed with acini. The ratio of the diameter of the
lumen to the height of the epithelium is in the range of
1:1. These lesions occur less frequently than either
AACN or cystic ductal complexes.
The pancreas of MNCO-treated rats contains a larger
spectrum of lesions than are usually seen after azaserine treatment, but we have seen a low incidence and
small number of both cystic and tubular ductal complexes in azaserine-treated rats. The lesions that appear to have the greatest potential for progression to
neoplasia appear to be the AACN which are presumed
to be the precursors to acinar cell adenomas and
carcinomas. More than 100 such foci have been counted
in a pancreas from a rat given multiple doses of MNCO.
It is apparent that this genotoxic initiator, like azaserine,
BOP, and HPOP, can induce many potentially preneoplastic foci in the rat pancreas.

MNCO-Induced Lesions in
Hamster Pancreas
We have recently reported the induction of ductlike
carcinomas in the pancreas of Syrian golden hamsters
that were treated with MNCO (2). We had earlier

reported the effect of smaller doses of MNCO in a
6-month study (16). The histologic appearance of these
carcinomas was similar to those that have been induced
by BOP and related compounds. MNCO induced a
spectrum of lesions in the hamster pancreas similar to
that already described in the rat. Several foci of atypical
acinar cells were observed (Fig. 3). The incidence was
related to the total dose of MNCO, but it was always
less than 100%, and there were usually only one or two
such lesions per pancreas. We also observed a doserelated incidence of cystic ductal complexes and occasional tubular ductal complexes that replaced lobular
acinar tissue (Fig. 4). The latter structures are similar
to the BHP-induced lesions in the hamster that Flaks
has called "pseudoductular transformation" (17). Some
lesions had characteristics of both cystic ductal complexes and tubular ductal complexes while occasional
AACN had tubular units similar to those seen in tubular
ductal complexes. Thus, while most lesions could easily
be categorized as AACN, tubular ductal complexes, or
cystic ductal complexes, there were some borderline
lesions that were difficult to classify. This suggests the
possibility that tubular ductal complexes and cystic
ductal complexes might have been derived from carcinogen-altered acinar cells. We also saw a dose-related
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FIGURE 3. Focus of atypical acinar cells from the pancreas of a hamster that was autopsied 32 weeks after initial MNCO treatment. H & E,
x 130.
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FIGURE 4. Tubular ductal complex from the pancreas of an MNCO-treated hamster that was autopsied after 26 weeks. H & E,

x 325.
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incidence of focal eosinophilic metaplasia similar to
lesions described in aged hamsters by Pour (18) and
BOP-treated hamsters by Scarpelli et al. (19). We did
not undertake ultrastructural or histochemical studies
to verify hepatocytelike characteristics for these cells;
however, their histologic appearance was consistent
with this phenotype.
Many ducts and ductules were normal, but infrequent
examples of intraductal papillary epithelial hyperplasia,
atypical papillary intraductal hyperplasia, and intraductal carcinoma were seen. The histologic type of most
carcinomas was consistent with derivation from either
tubular ductal complexes or intraductal proliferative
lesions, but no final conclusion regarding the relative
importance of these two putative precursors was
established.

AcinAcina
cell

Conclusions

Proliferative lesions of acinar cells have been the most
frequent manifestation of systemic exposure to pancreatic carcinogens in the rat.

Our studies of rats and hamsters suggests that
exogenous chemical carcinogens can affect acinar cells
in both species and ductal cells in hamsters. A composite scheme outlining the possible sequences for the
histogenesis of carcinogen-induced lesions in the pancreas of rats and hamsters is depicted in Figure 5.
Experience with several carcinogens supports the view
that the carcinogen-induced lesions are derived primarily, or exclusively, from acinar cells in the rat
pancreas (5). HPOP and MNCO are carcinogens that
induce acinar cell carcinomas in the rat and ductlike
carcinomas in the hamster. Thus, the response of these
two species to specific chemical carcinogens differs in a
consistent fashion. Pathways have been proposed in
both the rat and the hamster whereby ductlike carcinomas might arise from carcinogen-altered acinar tissue.
The possibility that the carcinomas induced by these
two carcinogens arise from acinar cells in both rats and
hamsters should be considered, although the data we
have presented is no more than suggestive of this
pathway. We also consider the alternate possibility that
the carcinomas arise from different cells of the pancreas
in the two species, i.e., acinar cells in the rat and ductal
cells in the hamster. The pathways outlined in Figure 5
do not reflect the view of Pour that ductal complexes
arise by proliferation of ductular and/or centroacinar
cells (20). The relative importance of lesions derived
from the two cell types in regard to the origin of
carcinomas in the hamster is unknown. We believe that
a similar situation pertains in regard to pancreatic
carcinogenesis in the human, i.e., that the relative
proportion of tumors arising as a result of transformation of acinar cells and ductal cells is not known with

certainty.
Experience with the number and types of lesions that
have been induced in the rat pancreas by genotoxic
carcinogens such as azaserine, BOP, HPOP, and MNCO
provides a basis for comparison and evaluation of the
carinogenic potential of additional chemical agents.
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FIGURE 5. Pathways for derivation of carcinogen-induced lesions and
carcinomas in rodent pancreas. See the text for a discussion of the
histologic types of carcinomas derived from duct cells and acinar
cells. The duct cell* is intended to represent ductal, ductular and
centroacinar cells.
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